Pancreatic Cancer Surgery

Introduction

A diagnosis of pancreatic cancer brings many decisions at once. You may be meeting a surgical oncologist, an oncologist who plans chemotherapy, a radiologist who interprets your scans, and a nutritionist — sometimes in the same week. Of all the treatments discussed, surgery is the one that offers the strongest chance of long-term disease control when the tumour can be completely removed.

Pancreatic cancer surgery is one of the most demanding operations in the field of surgical oncology. It is performed by specialist hepatopancreatobiliary (HPB) surgeons — surgeons who focus on the liver, pancreas, and bile ducts — in centres equipped with experienced anaesthesia, intensive care, interventional radiology, and gastroenterology teams. Outcomes after this surgery are strongly tied to how often a centre performs it, which is why these operations are typically concentrated in high-volume hospitals.

This guide explains what pancreatic cancer surgery involves, who is considered a candidate, the different operations and approaches used, how to prepare, what happens during and after surgery, the risks, and what life looks like in the months and years that follow. It is written for patients and families who are planning the next phase of care after a diagnosis has been made.

What Is Pancreatic Cancer Surgery?

The pancreas is a long, soft gland that sits deep in the upper abdomen, behind the stomach. It has two main jobs. It releases digestive enzymes into the small intestine to help break down food, and it produces hormones — including insulin — that regulate blood sugar. The pancreas is divided into four parts: the head (closest to the small intestine), the neck, the body, and the tail (closest to the spleen).

The most common cancer of the pancreas is pancreatic ductal adenocarcinoma, which arises from the cells lining the small ducts that carry digestive enzymes. Less common types include neuroendocrine tumours and cystic tumours, which behave differently and may have different surgical approaches. The information in this article focuses primarily on adenocarcinoma, which makes up the large majority of pancreatic cancers.

Pancreatic cancer surgery is the operation performed to remove the cancerous portion of the pancreas along with nearby tissues that may contain microscopic disease. The goals of the operation are:

• To remove the tumour completely, with a rim of healthy tissue around it (called clear or negative margins)
• To remove regional lymph nodes for examination, since this affects the staging and the chemotherapy plan
• To rebuild the digestive tract so that food, bile, and pancreatic juice can continue to flow normally

Because the pancreas sits next to major blood vessels, the bile duct, the stomach, the duodenum (first part of the small intestine), the spleen, and the colon, pancreatic cancer surgery is rarely a small operation. It almost always involves removing more than just the pancreas itself.

Why Is Pancreatic Cancer Surgery Performed?

Surgery is performed when removing the tumour offers a realistic chance of long-term disease control or cure. For pancreatic adenocarcinoma, complete surgical removal followed by chemotherapy is the only treatment combination currently shown to offer the possibility of long-term survival. Chemotherapy and radiation alone, without surgery, can control the disease but do not currently cure it.

Doctors consider surgery when imaging and biopsy results suggest that:

• The tumour is limited to the pancreas, or has only limited contact with nearby structures that can also be safely removed
• There is no spread to distant organs such as the liver, lungs, or the lining of the abdomen (peritoneum)
• Important blood vessels — particularly the superior mesenteric artery, the coeliac artery, and the portal vein — are either free of tumour or can be reconstructed safely
• The patient is medically fit enough to undergo and recover from a major abdominal operation

• Resectable — the tumour can be removed with surgery upfront
• Borderline resectable — the tumour touches important blood vessels but may become removable after initial chemotherapy (and sometimes radiation) to shrink it
• Locally advanced — the tumour has grown into vessels in a way that prevents safe removal
• Metastatic — the cancer has spread to other organs

Surgery with curative intent is generally performed for resectable and selected borderline resectable disease. In locally advanced and metastatic disease, surgery may still play a role — sometimes to relieve symptoms such as a blocked bile duct or blocked stomach outlet — but is not usually aimed at cure.

Estimates from published series suggest that only about 15–20 per cent of patients have disease that is removable at the time of diagnosis. This is one of the reasons pancreatic cancer remains a difficult disease, and one of the reasons specialist evaluation is so important — the line between borderline resectable and locally advanced can be subtle and benefits from review at a multidisciplinary tumour board.

Who Is a Candidate?

Being a candidate for pancreatic cancer surgery depends on two questions: is the cancer removable, and is the body able to recover from the operation?

On the cancer side, surgeons and oncologists assess:

• Tumour location within the pancreas (head, neck, body, or tail)
• Tumour size and contact with nearby blood vessels
• Presence or absence of involved lymph nodes
• Whether the disease has spread elsewhere
• The tumour’s response to any chemotherapy given before surgery

On the patient side, the team assesses:

• Overall fitness, often measured by functional status (how active you are in daily life)
• Heart and lung function
• Nutritional state — weight loss, low albumin, and muscle loss are common with pancreatic cancer and affect recovery
• Diabetes control, since the pancreas is involved in blood sugar regulation
• Liver function, particularly if the bile duct has been blocked by the tumour
• Other medical conditions and the medicines you take

Age alone is not a barrier. Many older patients undergo pancreatic cancer surgery safely when their overall fitness is good. What matters more than age is the presence or absence of other serious illnesses and the strength of the support system at home.

Alternatives and Complementary Treatments

Even when surgery is the central treatment for resectable disease, it is almost never used alone. Modern pancreatic cancer care is multidisciplinary and combines surgery with other treatments. For some patients, surgery is not appropriate, and the other treatments become the main approach.

Chemotherapy

Chemotherapy is the most important non-surgical treatment for pancreatic cancer. The two regimens most often used today are FOLFIRINOX (a combination of four drugs) and gemcitabine combined with nab-paclitaxel. Major guidelines from NCCN, ASCO, and ESMO support these as the principal options, with the choice depending on the patient’s fitness, side effect profile, and tumour features.

Chemotherapy may be given:

• Before surgery (neoadjuvant) — particularly for borderline resectable disease, and increasingly considered even for resectable disease, to treat any microscopic spread early and to test whether the tumour responds
• After surgery (adjuvant) — to reduce the chance of recurrence, usually starting once recovery from surgery is sufficient
• As the main treatment — in locally advanced or metastatic disease

Radiation therapy

Radiation may be added in selected situations, often combined with chemotherapy. It is used more commonly in borderline resectable and locally advanced disease, and sometimes after surgery if the margins were close or positive. Stereotactic body radiation therapy (SBRT) delivers focused, high-dose radiation in fewer sessions and is increasingly used in specialist centres.

Targeted therapy and immunotherapy

A small proportion of pancreatic cancers have specific genetic features — such as BRCA mutations or mismatch repair deficiency — that respond to targeted drugs or immunotherapy. Tumour genetic testing is increasingly part of standard evaluation in major centres.

Palliative procedures

When the cancer cannot be removed, smaller procedures may still relieve symptoms and improve quality of life. These include placing a stent to open a blocked bile duct or duodenum, surgical bypasses for blockages, and nerve block procedures to control pain.

Watchful waiting and supportive care

For patients whose disease is widespread or whose overall health is too fragile for active treatment, the focus may shift to symptom control, nutrition, and quality of life. This is sometimes called best supportive care or palliative care, and it can be delivered alongside other treatments at any stage.

Types of Pancreatic Cancer Surgery

The specific operation depends mainly on where the tumour sits within the pancreas. There are three main operations.

Whipple Procedure (Pancreaticoduodenectomy)

The Whipple operation is the most common pancreatic cancer surgery, performed for tumours in the head or neck of the pancreas (which is where roughly two-thirds of pancreatic cancers occur). It is a large operation because the head of the pancreas shares blood supply and ducts with several other organs, all of which need to be addressed.

The surgeon typically removes:

• The head of the pancreas
• The duodenum (the first part of the small intestine)
• The gallbladder
• The lower portion of the bile duct
• Sometimes a portion of the stomach (in the classic Whipple) or the lower stomach is preserved (in the pylorus-preserving variant)
• Regional lymph nodes

The surgeon then reconstructs the digestive tract by connecting the remaining pancreas, bile duct, and stomach to the small intestine, so that pancreatic juice, bile, and food can again flow into the digestive system. This reconstruction creates three new connections (called anastomoses), each of which must heal carefully.

The Whipple operation typically takes six to eight hours and is one of the most technically demanding operations in general surgery. It is performed in specialist centres for this reason.

Distal Pancreatectomy

This operation is shorter and somewhat less complex than the Whipple because no major digestive reconstruction is needed — the cut end of the remaining pancreas is closed or, in some centres, connected to a loop of bowel. The spleen helps fight certain bacterial infections, so patients who have their spleen removed receive vaccinations beforehand against pneumococcus, meningococcus, and Haemophilus influenzae type b.

In selected centres, a variant called radical antegrade modular pancreatosplenectomy (RAMPS) is used to achieve a wider clearance of tissue behind the pancreas.

Total Pancreatectomy

Total pancreatectomy — removal of the entire pancreas — is used less often. It may be chosen when the tumour involves multiple parts of the pancreas, when there are multiple tumours, when the remaining pancreas is too soft or diseased to safely reconstruct, or in certain genetic cancer syndromes.

Because the whole pancreas is removed, the patient loses all insulin production and all digestive enzyme production. This means lifelong insulin therapy and lifelong pancreatic enzyme replacement with meals. Modern care has improved the management of this “brittle” form of diabetes considerably, but it remains a significant adjustment and is one of the reasons total pancreatectomy is reserved for situations where it is genuinely necessary.

Surgical Approaches

In addition to the type of operation, there is the question of how the surgeon accesses the pancreas. There are three main approaches.

Open Surgery

In open pancreatic cancer surgery, the surgeon makes a single larger incision in the upper abdomen and operates directly through it. Open surgery is the long-established approach and remains the standard for the Whipple operation in most centres worldwide, particularly when the tumour is in close contact with major blood vessels or when vascular reconstruction is needed.

Laparoscopic Surgery

Laparoscopic surgery uses several small incisions through which a camera and long instruments are inserted. The surgeon operates while watching a high-definition screen. Laparoscopic distal pancreatectomy is now well established in specialist centres and is often offered for tumours in the body and tail. Laparoscopic Whipple is performed in a smaller number of expert centres and remains technically demanding.

Robotic Surgery

Robotic surgery is a form of minimally invasive surgery in which the surgeon controls instruments through a console. The robotic platform offers greater precision and dexterity, particularly for the fine stitching needed during pancreatic reconstruction. Robotic distal pancreatectomy and, increasingly, robotic Whipple are performed in selected high-volume centres.

The choice between open, laparoscopic, and robotic approaches depends on the operation needed, the tumour’s location and relationship to blood vessels, the surgeon’s experience, and the resources of the centre. Current evidence suggests that, when performed by experienced teams, minimally invasive approaches can offer faster recovery and shorter hospital stays for selected operations, while the long-term cancer outcomes are broadly similar to open surgery. For complex cases involving the blood vessels, open surgery remains the standard.

Preparing for Pancreatic Cancer Surgery

Preparation for pancreatic cancer surgery is unusually thorough. The pre-operative phase often takes several weeks, particularly when neoadjuvant chemotherapy is given first.

Imaging and staging

Before surgery, you will have:

• A specialised pancreas-protocol contrast-enhanced CT scan, which is the most important imaging study for surgical planning
• An MRI of the pancreas in some cases, particularly to look at the bile duct or to clarify findings on CT
• Endoscopic ultrasound (EUS), often combined with a fine-needle biopsy to confirm the diagnosis
• A PET-CT scan in selected cases to look for spread
• Sometimes a diagnostic laparoscopy — a small look inside the abdomen with a camera — if there is concern about small spread that imaging might miss

Blood tests

Tests include a full blood count, liver and kidney function, blood sugar (HbA1c), nutritional markers, and the tumour marker CA 19-9. CA 19-9 is not used to diagnose pancreatic cancer but can help track response to treatment and detect recurrence.

Multidisciplinary tumour board

Your case will usually be discussed at a multidisciplinary tumour board, where surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, and gastroenterologists review the findings together and agree on a treatment plan. This is an important step and is considered standard practice for pancreatic cancer in major centres.

Pre-operative procedures

If the bile duct is blocked by the tumour, jaundice (yellowing of the skin and eyes) and itching often develop. A stent may be placed through an endoscopic procedure (ERCP) to drain the bile before surgery, particularly if neoadjuvant chemotherapy is planned.

Nutrition and prehabilitation

Many people with pancreatic cancer have lost weight before diagnosis. Pre-operative nutrition support — sometimes including pancreatic enzyme supplements, dietary counselling, and high-calorie supplements — can improve recovery. Prehabilitation programmes that combine nutrition, gentle exercise, and breathing exercises in the weeks before surgery are increasingly used and have been shown to improve outcomes in major abdominal surgery.

Medical optimisation

The team will review your medicines — blood thinners, diabetes medicines, and others — and adjust them ahead of surgery. Smoking cessation is strongly encouraged. Vaccinations are given if the spleen is to be removed. Anaesthesia and cardiac assessment confirm fitness for major surgery.

What Happens During Pancreatic Cancer Surgery

Pancreatic cancer surgery is performed under general anaesthesia. You will be asleep throughout, with a breathing tube and full monitoring. The operation involves several stages.

Assessment: The surgeon first looks inside the abdomen, sometimes laparoscopically before the main operation, to confirm that there is no spread of disease that imaging missed. If unexpected spread is found, the planned operation may be modified or stopped.

Mobilisation: The surgeon carefully separates the pancreas from surrounding structures, identifying and protecting the major blood vessels.

Resection: The diseased portion of the pancreas and the associated organs (duodenum, bile duct, gallbladder, sometimes part of the stomach, sometimes the spleen) are removed along with regional lymph nodes. In selected cases, a portion of the portal vein or superior mesenteric vein is removed and reconstructed.

Reconstruction: In the Whipple operation, the surgeon connects the remaining pancreas, the bile duct, and the stomach to the small intestine. In distal pancreatectomy, the cut end of the pancreas is sealed. In total pancreatectomy, the bile duct and stomach are connected directly to the small intestine.

Closure: Drains are placed near the new connections to allow any leaking fluid to escape and to alert the team if there is a problem. The abdomen is closed.

A Whipple operation typically takes six to eight hours; distal pancreatectomy is usually shorter. Blood transfusion may or may not be needed.

Recovery and Healing

Recovery from pancreatic cancer surgery is gradual and unfolds in phases.

The hospital phase

Most patients spend the first one to three days in an intensive care or high-dependency unit, where breathing, blood pressure, blood sugar, and pain are closely monitored. The breathing tube is usually removed soon after surgery.

Total hospital stay typically ranges from 7 to 14 days, depending on the operation and on how recovery progresses. Key elements of the hospital phase include:

• Pain control, often using a combination of intravenous medicines and sometimes an epidural
• Early mobilisation — sitting up and walking short distances within a day or two of surgery, which reduces lung problems and blood clots
• Breathing exercises to keep the lungs clear
• Gradual reintroduction of diet, starting with sips of water and progressing as the digestive tract recovers
• Monitoring of the drains for signs of pancreatic leak or bile leak
• Blood sugar monitoring, since the operation affects insulin production
• Blood-thinning injections to reduce the risk of clots

Enhanced recovery after surgery (ERAS) protocols — structured pathways that combine many small evidence-based steps — are now used in many centres and have been shown to shorten hospital stay and reduce complications.

The first weeks at home

After discharge, most patients feel weak and tired. Appetite is reduced, and meals are smaller and more frequent than before. Some weight loss continues for a while. Walking daily, gradually increasing the distance, is one of the most important parts of early recovery.

• Weeks 1–2: Focus on rest, gentle walking, pain control, wound healing, and gradually expanding the diet
• Weeks 3–6: Energy slowly returns, walking distance increases, light household activity becomes possible
• Weeks 6–12: Most patients feel substantially stronger, can resume light work, and are often ready to start adjuvant chemotherapy if it is part of the plan
• 3–6 months: A new baseline is reached, with appetite, weight, and strength stabilising

Driving, heavier lifting, and full return to work depend on the type of work and the operation, and are discussed at follow-up visits. Recovery may take longer if chemotherapy is given afterwards, since chemotherapy itself causes fatigue and other side effects.

Digestive changes

After pancreatic cancer surgery, the digestive system works differently. The remaining pancreas may not produce enough enzymes to digest fats and proteins, leading to fatty, loose stools and weight loss. This is called pancreatic exocrine insufficiency. Pancreatic enzyme replacement therapy — capsules taken with meals — is commonly prescribed and significantly improves digestion, nutrition, and quality of life.

Smaller, more frequent meals are usually better tolerated than three large meals. A dietitian familiar with pancreatic surgery can help with planning. Vitamin deficiencies, particularly fat-soluble vitamins (A, D, E, K) and vitamin B12 (especially after total pancreatectomy), are checked at follow-up and treated if needed.

Blood sugar

Blood sugar changes are common. Some patients develop new diabetes or find that existing diabetes is harder to control. Patients who undergo total pancreatectomy will always need insulin. Diabetes after pancreatic surgery sometimes behaves differently from typical type 1 or type 2 diabetes and benefits from input from an endocrinologist familiar with this condition.

Risks and Complications

Pancreatic cancer surgery carries higher risks than most other cancer operations. Outcomes are significantly better when the operation is performed in high-volume centres — hospitals that perform many pancreatic resections each year and have the supporting infrastructure to manage complications quickly. This volume-outcome relationship is one of the most consistent findings in surgical literature for this disease.

Possible complications include:

• Pancreatic fistula (leak) — leakage of pancreatic fluid from the new connection, which is the most characteristic complication of pancreatic surgery. The International Study Group of Pancreatic Surgery (ISGPS) grades fistulas from biochemical leak to severe. Most are managed with drains and nutrition support; a minority need re-intervention.
• Delayed gastric emptying — the stomach is slow to empty after surgery, causing nausea and bloating. It usually resolves over weeks and is managed with medicines, dietary changes, and sometimes a feeding tube.
• Bleeding — either during or after surgery. Post-operative bleeding can sometimes occur days after surgery and is treated by interventional radiology or repeat surgery.
• Infection — in the wound, in the abdomen (sometimes as a collection requiring drainage), in the lungs (pneumonia), or in the urinary tract
• Blood clots in the legs or lungs, which is why blood-thinning injections are routinely used
• Bile leak from the new bile duct connection
• Anastomotic strictures — narrowing of the new connections in the months or years afterwards, occasionally requiring treatment
• New or worsening diabetes
• Pancreatic exocrine insufficiency requiring enzyme replacement
• Heart, lung, or kidney problems related to major surgery, particularly in patients with pre-existing conditions

Mortality rates after pancreatic cancer surgery have improved significantly over recent decades and are now reported in the low single digits at high-volume centres, but they remain higher than for many other operations. This is a major reason for concentrating these operations in specialist hospitals.

Life After Pancreatic Cancer Surgery

Life after pancreatic cancer surgery involves both medical follow-up for the cancer and longer-term adjustments to digestion, nutrition, and energy.

Adjuvant chemotherapy

For most patients with pancreatic adenocarcinoma, chemotherapy is recommended after surgery to reduce the risk of recurrence. It typically starts six to twelve weeks after the operation, once recovery is sufficient. Current major regimens include modified FOLFIRINOX (for patients who are fit enough to tolerate it) and gemcitabine-based combinations. The choice is made by the medical oncologist based on fitness, surgical recovery, and the tumour’s features.

If chemotherapy was given before surgery (neoadjuvant), the post-operative plan may involve completing the planned course or moving directly to surveillance, depending on what was already given and how the tumour responded.

Surveillance

After treatment is complete, regular follow-up looks for recurrence and supports recovery. A typical schedule includes:

• Clinical review every three to six months for the first two to three years, then less frequently
• CA 19-9 blood test at each visit
• CT scans every three to six months in the early years
• Nutritional review and dietitian input
• Blood sugar checks and diabetes review
• Vitamin and mineral checks

The risk of recurrence is highest in the first two years. Many recurrences appear at the original site or in the liver. If a recurrence is found, treatment options include further chemotherapy, radiation, clinical trial participation, and, in selected cases, further surgery.

Nutrition and weight

Many patients find that they can eat well after recovery but at smaller volumes than before. Pancreatic enzyme replacement, taken consistently with meals and snacks, is one of the most important contributors to good nutrition. Working with a dietitian over the long term is helpful for many patients.

Energy and quality of life

Energy gradually improves but may not fully return to pre-surgery levels for several months, particularly when adjuvant chemotherapy is given. Exercise — especially walking — is one of the most reliable ways to rebuild strength and improve well-being.

Emotional health

A pancreatic cancer diagnosis and its treatment place a heavy emotional load on patients and families. Anxiety about recurrence, called “scanxiety”, is common around the time of follow-up scans. Counselling, peer support groups, and mental health support are important parts of long-term care and are increasingly integrated into cancer follow-up clinics.

Outlook After Surgery

Survival after pancreatic cancer surgery depends on many factors, including the stage of disease, whether all the tumour was removed with clear margins, whether lymph nodes were involved, the tumour’s biology, response to chemotherapy, and overall health. Published series suggest that long-term survival is much more likely when the cancer can be completely removed and is followed by chemotherapy than when surgery is not possible. Even within the group of patients who undergo surgery, outcomes vary widely, and the medical oncology team can give personalised estimates based on the final pathology and treatment plan.

What is consistent across reported data is that complete surgical removal combined with effective chemotherapy is currently the only treatment path with a realistic chance of long-term survival in pancreatic adenocarcinoma. The decades of work that have gone into refining surgical techniques, multidisciplinary care, and chemotherapy have shifted outcomes meaningfully forward compared with earlier eras, although pancreatic cancer remains one of the more difficult cancers to treat.

Frequently Asked Questions

How long does pancreatic cancer surgery take?

A Whipple operation typically takes six to eight hours. Distal pancreatectomy is usually shorter, often three to five hours. Total pancreatectomy varies depending on the extent of disease. Times depend on the approach (open, laparoscopic, robotic), whether blood vessel reconstruction is needed, and the patient’s anatomy.

Will I need chemotherapy if surgery removed all the cancer?

For pancreatic adenocarcinoma, adjuvant chemotherapy is recommended in most cases, even when surgery appears to have removed all visible disease. Major guidelines support this because microscopic cancer cells can remain and chemotherapy reduces the chance of recurrence. The specific regimen is chosen by the medical oncologist.

Will I become diabetic after pancreatic cancer surgery?

It depends on which operation is done. After a Whipple or distal pancreatectomy, some patients develop new diabetes or find existing diabetes harder to control, while others maintain normal blood sugar. After total pancreatectomy, insulin therapy is always needed because the pancreas no longer produces insulin.

Will I need to take enzyme replacement for life?

Many patients do, particularly after Whipple or total pancreatectomy. Pancreatic enzyme replacement helps digest food and prevents weight loss and vitamin deficiencies. Whether and at what dose it is needed is reviewed by the surgical and dietetic team based on symptoms and stool patterns.

What is the difference between a Whipple operation and a pancreaticoduodenectomy?

They are the same operation. “Whipple” is the common name (after the surgeon who refined the procedure), and “pancreaticoduodenectomy” is the technical name. A variant that preserves the pylorus (the outlet of the stomach) is called pylorus-preserving pancreaticoduodenectomy (PPPD).

Can pancreatic cancer surgery be done laparoscopically or with a robot?

Yes, in selected cases and in centres with experienced teams. Minimally invasive distal pancreatectomy is well established. Minimally invasive Whipple operations are performed in a smaller number of expert centres. The choice depends on tumour location, vascular involvement, and the surgeon’s experience. For complex tumours involving major blood vessels, open surgery is generally preferred.

How soon will I know if the surgery removed all the cancer?

The pathology report, which examines the removed tissue under the microscope, usually becomes available within one to two weeks. It tells you about tumour size, lymph node involvement, margin status (whether the edges are free of tumour), and other features. The oncology team uses this report to plan adjuvant treatment.

What if the cancer comes back?

If pancreatic cancer recurs after surgery, treatment options include chemotherapy, radiation therapy, clinical trial participation, and, in selected cases, further surgery or other local treatments. The plan is individualised based on where the recurrence is found, how long after surgery it appeared, the patient’s overall health, and previous treatments.

Does pancreatic cancer affect children?

Pancreatic adenocarcinoma is overwhelmingly a disease of adults, and is extremely rare in children. Children with pancreatic tumours usually have different types — such as pancreatoblastoma or solid pseudopapillary tumour — which are managed by specialist paediatric oncology teams and have their own treatment approaches.

Why is it important to have this surgery in a specialist centre?

Outcomes after pancreatic cancer surgery are strongly linked to how often the centre and surgeon perform the operation. High-volume centres tend to have lower complication and mortality rates, more experience managing the specific complications of pancreatic surgery, and stronger multidisciplinary teams. This is one of the most consistent findings in modern surgical research and is a major reason most professional societies encourage care in specialist HPB centres.

Conclusion

Pancreatic cancer surgery is a major undertaking, but for patients whose disease can be removed, it currently offers the strongest chance of long-term survival. The operation that fits a particular patient depends on where the tumour sits, how it relates to surrounding blood vessels, and overall health. Whipple operations, distal pancreatectomies, and total pancreatectomies each have a role, and modern approaches — open, laparoscopic, and robotic — allow surgical teams to match the technique to the situation.

Recovery is gradual. The first weeks focus on basic healing, the following months on regaining strength, often while undergoing chemotherapy. Long-term life after surgery involves attention to digestion, nutrition, blood sugar, and regular follow-up to detect recurrence early. Throughout, the value of a multidisciplinary team — surgeons, oncologists, radiologists, pathologists, dietitians, and supportive care specialists working together — is central to good outcomes.

A diagnosis of pancreatic cancer is one of the most difficult conversations any patient and family can have. Understanding the role of surgery, what it can and cannot achieve, and what life looks like during and after treatment can help in making informed decisions in partnership with the medical team.